These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15432453)
1. Studies on the use of aureomycin in hepatic disease. IV. Aureomycin therapy in chronic liver disease; with a note on dermal sensitivity. SHAFFER JM; BLUEMLE LW; SBOROV VM; NEEFE JR Am J Med Sci; 1950 Aug; 220(2):173-82. PubMed ID: 15432453 [No Abstract] [Full Text] [Related]
2. Studies on the use of aureomycin in hepatic disease. III. A note on aureomycin therapy in hepatic coma. FARQUHAR JD; STOKES J; WHITLOCK CM; BLUEMLE LW; GAMBESCIA JM Am J Med Sci; 1950 Aug; 220(2):166-72. PubMed ID: 15432452 [No Abstract] [Full Text] [Related]
3. Studies on the use of aureomycin in hepatic disease. II. The effect of aureomycin on experimental dietary hepatic necrosis. GYORGY P; STOKES J; SMITH WH; GOLDBLATT H Am J Med Sci; 1950 Jul; 220(1):6-11. PubMed ID: 15425509 [No Abstract] [Full Text] [Related]
4. Fatty liver following aureomycin and terramycin therapy in chronic hepatic disease. SBOROV VM; SUTHERLAND DA Gastroenterology; 1951 Aug; 18(4):598-605. PubMed ID: 14860396 [No Abstract] [Full Text] [Related]
5. Studies on the use of aureomycin in hepatic disease. I. Aureomycin therapy in acute viral hepatitis. SHAFFER JM; FARQUHAR JD; STOKES J; SBOROV VM Am J Med Sci; 1950 Jul; 220(1):1-5. PubMed ID: 15425508 [No Abstract] [Full Text] [Related]
6. Aureomycin in the treatment of hepatic failure. GOLDBLOOM R; STEIGMANN F; POPPER H J Lab Clin Med; 1950 Nov; 36(5):826-7. PubMed ID: 14784695 [No Abstract] [Full Text] [Related]
7. A note on fatty change in the liver complicating aureomycin therapy. SAINT EG; JOSKE RA Med J Aust; 1953 Feb; 1(7):222-4. PubMed ID: 13036532 [No Abstract] [Full Text] [Related]
8. [Aureomycin therapy of chronic diseases of the liver]. BULIC F; MIKES A; RUSTENBEGOVIC F; JANCIC M Srp Arh Celok Lek; 1953 Jun; 81(6):618-26. PubMed ID: 13102020 [No Abstract] [Full Text] [Related]
9. Nitrogen metabolism and liver histology during aureomycin administration in patients with hepatic disease. FALOON WW; NOLL JW; PRIOR JT J Lab Clin Med; 1953 Apr; 41(4):596-607. PubMed ID: 13045012 [No Abstract] [Full Text] [Related]
13. [Aureomycin therapy of amebiasis; findings and evaluation of a fatal case with localizations in the colon, liver and lungs]. SCAFFIDI V; LI VOLSI M Acta Med Ital Mal Infett Parassit; 1952 Jul; 7(7):169-77. PubMed ID: 13007378 [No Abstract] [Full Text] [Related]
14. [Aspiration liver biopsy and local aureomycin in a case of amebic liver abscess; cure]. FEDI A; MIRACCO A Riforma Med; 1952 Jun; 66(23):625-7. PubMed ID: 14949947 [No Abstract] [Full Text] [Related]
15. [Effects of aureomycin in experimental liver disease by carbon tetrachloride]. FERIOLI V; RASTELLI G Riv Patol Clin; 1955 Jan; 10(1):39-48. PubMed ID: 13351397 [No Abstract] [Full Text] [Related]
16. [Hepatorenal fatty degeneration due to aureomycin]. ALBERTO P Minerva Med; 1953 Feb; 44(13):384-94. PubMed ID: 13071851 [No Abstract] [Full Text] [Related]